相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and associated risk factors of dry eye disease in 16 northern West bank towns in Palestine: a cross-sectional study
Yousef Shanti et al.
BMC OPHTHALMOLOGY (2020)
Repurposing anticancer drugs for the management of COVID-19
Khalid El Bairi et al.
EUROPEAN JOURNAL OF CANCER (2020)
Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du et al.
MOLECULAR CANCER (2018)
Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders
Suzanne Hagan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Inflammatory Response in Dry Eye
Takefumi Yamaguchi
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
N. Wahlgren et al.
JOURNAL OF INTERNAL MEDICINE (2017)
TFOS DEWS II Management and Therapy Report
Lyndon Jones et al.
OCULAR SURFACE (2017)
TFOS DEWS II Definition and Classification Report
Jennifer P. Craig et al.
OCULAR SURFACE (2017)
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study
Eric D. Donnenfeld et al.
CORNEA (2016)
Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease
Victor L. Perez et al.
OCULAR SURFACE (2016)
Ocular Toxicity of Tyrosine Kinase Inhibitors
Mary Elizabeth Davis
ONCOLOGY NURSING FORUM (2016)
Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits
Leticia Rodrigues Parrilha et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2015)
Targeting Abl Kinases to Regulate Vascular Leak During Sepsis and Acute Respiratory Distress Syndrome
Alicia N. Rizzo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Small Molecule Discoidin Domain Receptor Kinase Inhibitors and Potential Medical Applications
Yupeng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
In Vivo Confocal Microscopy of the Ocular Surface: From Bench to Bedside
Edoardo Villani et al.
CURRENT EYE RESEARCH (2014)
Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation
Darlene A. Dartt et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis
Naotsugu Akashi et al.
Modern Rheumatology (2014)
Discoidin domain receptors in disease
Corina M. Borza et al.
MATRIX BIOLOGY (2014)
Spatial epidemiology of dry eye disease: findings from South Korea
Sun-Bi Um et al.
INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS (2014)
In-vivo confocal microscopy of the ocular surface: ocular allergy and dry eye
Edoardo Villani et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Imatinib Mesylate: An Innovation in Treatment of Autoimmune Diseases
Gholamreza Azizi et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2013)
Collagen I Induces Discoidin Domain Receptor (DDR) 1 Expression through DDR2 and a JAK2-ERK1/2-mediated Mechanism in Primary Human Lung Fibroblasts
Pedro A. Ruiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Imatinib mesylate attenuates fibrosis in coxsackievirus B3-induced chronic myocarditis
Carola Leipner et al.
CARDIOVASCULAR RESEARCH (2008)
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
Elizabeth Day et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Inflammatory markers in the tears of patients with ocular surface disease
Arantxa Acera et al.
OPHTHALMIC RESEARCH (2008)
Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1
Rahim Abdulhussein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1
Nafeesa A. Noordeen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation
AM Wolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats
H Yoshiji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Animal models of dry eye: A critical assessment of opportunities and limitations
S Barabino et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop
PP Ongusaha et al.
EMBO JOURNAL (2003)
Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases
KK Eklund et al.
ANNALS OF MEDICINE (2003)
Discoidin domain receptor (DDR)1 and 2: Collagen-activated tyrosine kinase receptors in the cornea
RR Mohan et al.
EXPERIMENTAL EYE RESEARCH (2001)
分享论文
